학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 98건 | 목록 1~20
Academic Journal
Goldring CE; Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. C.E.P.Goldring@liverpool.ac.uk.; Russomanno G; Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; Pin C; Systems Medicine, Clinical Pharmacology and Safety Sciences, R&D Department, AstraZeneca, Cambridge, UK.; Trairatphisan P; AbbVie Deutschland, Ludwigshafen, Germany.; Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.; Sanofi Research and Development, Frankfurt am Main, Germany.; Beattie KA; GSK Research and Development, Stevenage, UK.; Fisher CP; GSK Research and Development, Stevenage, UK.; Piñero J; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM) and Dept. of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain.; MedBioinformatics Solutions SL, Barcelona, Spain.; Brennan RJ; Sanofi Research and Development, Cambridge, MA, USA.; Clausznitzer D; AbbVie Deutschland, Ludwigshafen, Germany.; Copple IM; Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; de Kok TM; Department of Translational Genomics, GROW Research Institute for Oncology and Developmental Biology, Universiteit Maastricht, Maastricht, The Netherlands.; Duckworth CA; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; Furlong LI; Research Programme on Biomedical Informatics (GRIB), Hospital del Mar Medical Research Institute (IMIM) and Dept. of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra (UPF), Barcelona, Spain.; MedBioinformatics Solutions SL, Barcelona, Spain.; Füzi B; Universität Wien, Wien, Austria.; Gabor A; Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.; Gall L; Systems Medicine, Clinical Pharmacology and Safety Sciences, R&D Department, AstraZeneca, Cambridge, UK.; Hengstler J; Forschungsgesellschaft für Arbeitsphysiologie und Arbeitsschutz e.V, Dortmund, Germany.; Hermjakob H; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Hunter F; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Jennen D; Department of Translational Genomics, GROW Research Institute for Oncology and Developmental Biology, Universiteit Maastricht, Maastricht, The Netherlands.; Koskinen M; Orion Pharma, Orion Corporation, Espoo, Finland.; Kunnen SJ; Universiteit Leiden, Leiden, The Netherlands.; Lammens L; Galapagos NV, Mechelen, Belgium.; Lobentanzer S; Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.; Mohr M; Sanofi Research and Development, Frankfurt am Main, Germany.; Passini E; NC3Rs - National Centre for the Replacement, Refinement and Reduction of Animals in Research, London, UK.; Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, UK.; Pritchard DM; Department of Molecular and Clinical Cancer Medicine, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; Malik-Sheriff RS; European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Hinxton, UK.; Rodríguez B; Department of Computer Science, British Heart Foundation Centre of Research Excellence, University of Oxford, Oxford, UK.; Rossman EI; GSK, Collegeville, PA, USA.; Saez-Rodríguez J; Institute for Computational Biomedicine, Faculty of Medicine, Heidelberg University and Heidelberg University Hospital, Heidelberg, Germany.; Schmidt F; Sanofi Research and Development, Frankfurt am Main, Germany.; Sison-Young R; Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.; Soininen I; Synapse Research Management Partners, Madrid, Spain.; Turner S; AbbVie Deutschland, Ludwigshafen, Germany.; van de Water B; Universiteit Leiden, Leiden, The Netherlands.; van Hasselt JGC; Universiteit Leiden, Leiden, The Netherlands.; Venezia F; Institut de Recherches Internationales Servier, Suresnes, France.; Willy JA; Vertex Pharmaceuticals, Boston, MA, USA.; Leishman DJ; Eli Lilly and Company, Indianapolis, IN, USA.; Stevens JL; Universiteit Leiden, Leiden, The Netherlands.; Laplanche L; AbbVie Deutschland, Ludwigshafen, Germany. loic.laplanche@abbvie.com.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101124171 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1474-1784 (Electronic) Linking ISSN: 14741776 NLM ISO Abbreviation: Nat Rev Drug Discov Subsets: MEDLINE
Academic Journal
Livoti LA; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United Kingdom.; Sison-Young R; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United Kingdom.; Reddyhoff D; Certara Predictive Technologies, Sheffield, S1 2BJ, United Kingdom.; Fisher CP; Certara Predictive Technologies, Sheffield, S1 2BJ, United Kingdom.; GSK Research and Development Ltd, Stevenage, SG1 2NY, United Kingdom.; Gardner I; Certara Predictive Technologies, Sheffield, S1 2BJ, United Kingdom.; Diaz-Nieto R; Liverpool University Hospitals NHS Foundation Trust, Liverpool, L7 8YE, United Kingdom.; Goldring CE; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United Kingdom.; Copple IM; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool, L69 3GE, United Kingdom.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE
Academic Journal
Livoti LA; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom.; Sison-Young R; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom.; Reddyhoff D; Certara Predictive Technologies, Sheffield S1 2BJ, United Kingdom.; Fisher CP; Certara Predictive Technologies, Sheffield S1 2BJ, United Kingdom.; GSK Research and Development Ltd, Stevenage SG1 2NY, United Kingdom.; Gardner I; Certara Predictive Technologies, Sheffield S1 2BJ, United Kingdom.; Diaz-Nieto R; Liverpool University Hospitals NHS Foundation Trust, Liverpool L7 8YE, United Kingdom.; Goldring CE; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom.; Copple IM; Department of Pharmacology & Therapeutics, Institute of Systems, Molecular & Integrative Biology, University of Liverpool, Liverpool L69 3GE, United Kingdom.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE; In Process
Academic Journal
J Hepatol
Journal of Hepatology
Baxter, M, Withey, S, Harrison, S, Segeritz, C-P, Zhang, F, Atkinson-Dell, R, Rowe, C, Gerrard, D, Sison-Young, R, Jenkins, R, Henry, J, Berry, A, Mohamet, L, Best, M, Fenwick, S W, Malik, H, Kitteringham, N R, Goldring, C E, Piper Hanley, K, Vallier, L & Hanley, N 2015, 'Phenotypic and functional analyses show stem cell-derived hepatocyte-like cells better mimic fetal rather than adult hepatocytes', Journal of Hepatology, vol. 62, no. 3, pp. 581-589. https://doi.org/10.1016/j.jhep.2014.10.016
Academic Journal
Arch Toxicol
Archives of Toxicology
Heslop, J A, Rowe, C, Walsh, J, Sison-young, R, Jenkins, R, Kamalian, L, Kia, R, Hay, D, Jones, R P, Malik, H Z, Fenwick, S, Chadwick, A E, Mills, J, Kitteringham, N R, Goldring, C E P & Kevin Park, B 2017, ' Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profile ', Archives of toxicology . https://doi.org/10.1007/s00204-016-1694-y
Academic Journal
Toxicol Sci
Kia, R, Kelly, L, Sison-Young, R L C, Zhang, F, Pridgeon, C S, Heslop, J A, Metcalfe, P, Kitteringham, N R, Baxter, M, Harrison, S, Hanley, N A, Burke, Z D, Storm, M P, Welham, M J, Tosh, D, Küppers-Munther, B, Edsbagge, J, Starkey Lewis, P J, Bonner, F, Harpur, E, Sidaway, J, Bowes, J, Fenwick, S W, Malik, H, Goldring, C E P & Park, B K 2015, ' MicroRNA-122 : a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity ', Toxicological Sciences, vol. 144, no. 1, pp. 173-85 . https://doi.org/10.1093/toxsci/kfu269
Kia, R, Kelly, L, Sison-Young, RL, Zhang, F, Pridgeon, CS, Heslop, JA, Metcalfe, P, Kitteringham, NR, Baxter, M, Harrison, S, Hanley, N, Burke, ZD, Storm, MP, Welham, MJ, Tosh, D, Kuppers-Munther, B, Edsbagge, J, Starkey, L PJ, Bonner, F, Harpur, E, Sidaway, J, Bowes, J, Fenwick, SW, Malik, H, Goldring, CE & Park, BK 2015, 'MicroRNA-122: a novel hepatocyte-enriched in vitro marker of drug-induced cellular toxicity', Toxicological Sciences, vol. 144, no. 1, pp. 173-185.
TOXICOLOGICAL SCIENCES
Academic Journal
Ali SE; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Waddington JC; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Lister A; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Sison-Young R; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Jones RP; Department of Hepatobiliary Surgery, Aintree University Hospital, Liverpool University Hospitals, NHS Foundation Trust, Liverpool, UK.; Rehman AH; Department of Hepatobiliary Surgery, Aintree University Hospital, Liverpool University Hospitals, NHS Foundation Trust, Liverpool, UK.; Goldring CEP; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Naisbitt DJ; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.; Meng X; Department of Molecular & Clinical Pharmacology, University of Liverpool, Sherrington Buildings, Ashton Street, Liverpool, L69 3GE, UK.
Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited Medium: Internet ISSN: 1096-0929 (Electronic) Linking ISSN: 10960929 NLM ISO Abbreviation: Toxicol Sci Subsets: MEDLINE
Book
Advances in Pharmacology ISBN: 9780123983398
Sison-Young, R L C, Kia, R, Heslop, J, Kelly, L, Rowe, C, Cross, M J, Kitteringham, N R, Hanley, N, Park, B K & Goldring, C E P 2012, 'Human Pluripotent Stem Cells for Modeling Toxicity', Advances in Pharmacology, vol. 63, pp. 207-256. https://doi.org/10.1016/B978-0-12-398339-8.00006-9
Academic Journal
Ali SE; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Proteintech Group, 4th Floor, 196 Deansgate, Manchester M3 3WF, U.K.; Meng X; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Kafu L; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Hammond S; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Apconix Alderley Park, Alderley Edge, Cheshire SK10 4TG, U.K.; Zhao Q; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Ogese M; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Sison-Young R; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Jones R; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Department of Hepatobiliary Surgery, Aintree University Hospital, Liverpool University Hospitals, NHS Foundation Trust, Liverpool L9 7AL, U.K.; Chan B; Department of Hepatobiliary Surgery, Aintree University Hospital, Liverpool University Hospitals, NHS Foundation Trust, Liverpool L9 7AL, U.K.; Livoti L; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Sun Y; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Sun L; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Liu H; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Topping A; School of Engineering, The Quadrangle, The University of Liverpool, Brownlow Hill, Liverpool L69 3GH, U.K.; Goldring C; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.; Zhang F; Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venereology, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.; Naisbitt DJ; Department of Molecular and Clinical Pharmacology, University of Liverpool, Ashton Street, Liverpool L69 3GE, U.K.
Publisher: American Chemical Society Country of Publication: United States NLM ID: 8807448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5010 (Electronic) Linking ISSN: 0893228X NLM ISO Abbreviation: Chem Res Toxicol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Sison-Young, R.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어